United States alone, more than 1% of all infants born every year are conceived using ART [1] . Although techniques such as in vitro fertilization (IVF) have been used for decades, they do not come without a cost to human health. Most ARTs, especially IVF, are multistep processes comprising ovarian hyperstimulation, oocyte retrieval, fertilization, embryo culture, embryo selection, and embryo transfer. One obvious pitfall of ART is the increased risk of multiple pregnancies, because several embryos are often transferred to improve chances of success. Assisted reproductive technology has also been linked to genomic imprinting perturbations, leading to aberrant fetal growth and neurological disorders such as Angelman syndrome, Prader-Willi syndrome, and Beckwith-Wiedemann syndrome (reviewed in Gosden et al. [2] and Niemitz and Feinberg [3] ). Genomic imprinting is an epigenetic phenomenon leading to parental allele-specific gene expression, with DNA methylation serving as a key molecular mark involved in imprinted gene regulation (reviewed in Li and Sasaki [4] Lucifero et al. [5] ). A critical window for methylation imprint maintenance is the preimplantation stage of embryonic development, the same developmental window covered by in vitro culture of embryos undergoing ART. Fortunately, the absolute risk for an imprinting disorder following ART in humans remains low. Nonetheless, association of imprinting defects with ART is cause for concern in light of the evergrowing demand for this technology [1] .
Two issues intersect at the core of most problems associated with ART: suboptimal embryo culture conditions and a lack of empirically defined criteria guiding embryo selection prior to transfer. Resources supplied by the oocyte and embryonic genome activation support a form of selfsufficient development in the preimplantation embryo. Despite this autonomy, the embryo remains particularly susceptible to the environment in which it develops, and the stress imposed by the environment may exceed the developmental plasticity of the system (reviewed in Fleming et al. [6] and Schultz [7] ). This is especially true during in vitro culture, where conditions are rarely equivalent to the normal in vivo environment of the embryo. Studies done using a variety of animal models underscore the delicate balance between epigenetic, metabolic, proliferative, and homeostatic cues.
In line with observations made in some cases of ART, evaluation of genomic imprinting during in vitro culture of mouse preimplantation embryos revealed disruption of methylation imprint maintenance and abnormal imprinted gene expression [8] [9] [10] [11] [12] [13] . Additionally, in vitro culture of preimplantation embryos has been linked to altered expression of developmentally important genes, decreased embryo viability, reduced pregnancy rate following transfer, and abnormal metabolism, growth, and behavior in resulting offspring [9, 10, [14] [15] [16] [17] [18] [19] . Abnormal metabolism and energy production, oxidative stress, defective epigenome maintenance, atypical cell signaling, and nutrient deficiency caused by suboptimal culture conditions have all been postulated to contribute to the etiology of these developmental issues (reviewed in Fleming et al. [6] and Boerjan et al. [20] ).
In most species, including mice and humans, embryo selection following culture remains very much a subjective process where criteria such as cleavage rate and morphology serve to identify the ''healthiest'' candidates for transfer. Because embryo development is delayed in culture compared with in vivo development, embryos that develop more quickly have historically been considered the healthiest because they more closely follow the typical in vivo timeline. However, because of mitigated success, establishing defined scoring and evaluation systems to select the embryos most suitable for transfer and implantation remains imperative. Recent developments have focused on genomic, proteomic, and metabolomic profiling of embryos in culture in an effort to link viability and reproductive potential to specific signatures (reviewed in Aydiner et al. [21] Bromer and Seli [22] ). Application of spectroscopy and bioinformatics to noninvasive metabolomic profiling of human embryo culture media revealed a unique footprint for embryos with high reproductive potential compared with those failing to implant [23, 24] . Additional work done by Seli and colleagues [25] implies an even better correlation between metabolomic profiling and reproductive potential than the one from morphological analyses. These findings highlight a fundamental issue subjacent to the elaboration of effective selection criteria: which in vitrocultured embryos more faithfully resemble in vivo-derived embryos? Embryos developing more quickly, or those progressing more slowly? Faster-growing embryos currently ''make the cut'' when it comes to selection, but little is known concerning correlation of epigenetic or metabolic characteristics of embryos with their development rate in vitro.
In this issue of Biology of Reproduction, Market Velker and colleagues [26] add some perspective to this conundrum by relating the integrity of genomic imprinting to morphological stage in individual, in vitro-cultured mouse embryos. Based on current embryo selection criteria, the authors postulated that slower rates of development correlate with loss of imprinting and deviation from normal in vivo development, whereas faster-developing embryos more closely resemble in vivoderived embryos. The approach taken by the authors was simple yet elegant: two-cell-stage embryos recovered from naturally mated females were put in culture for 3 days, and over the course of the culture period they were separated into four groups according to their development rate. A number of parameters were then systematically evaluated in individual embryos, including methylation status and expression of imprinted genes, and related to morphological characteristics such as embryo cell number and volume. Surprisingly, the authors found the converse of their original hypothesis: embryos with slow to moderate rates of development were most similar to in vivo-derived embryos for all parameters evaluated. Not only was genomic imprinting better maintained in this group of slower-growing embryos, but expression of metabolic markers was also more consistent with that of in vivo-derived embryos. Faster-growing embryos exhibited more perturbation in genomic imprinting, suggesting an inability to faithfully maintain epigenetic information when embryos transition too rapidly through the first few embryonic divisions. This could potentially result from the stress imposed by less than adequate culture conditions.
There is no doubt further experimental research is needed to fully appreciate the limits of preimplantation development plasticity in vitro, and to understand how it impacts fetal and postpartum development, especially under suboptimal culture conditions. The work carried out by Market Velker et al. [26] is the first linking errors in genomic imprinting to faster development rates in in vitro-cultured embryos. When considering reproductive potential with respect to integrity of genomic imprinting, one would therefore argue against the selection and transfer of faster-growing embryos. This report also emphasizes the importance of developing noninvasive evaluation methods in conjunction with assessment of parameters such as genomic imprinting in animal models, because current morphological criteria clearly do not suffice. Future efforts aimed at associating specific metabolomic or proteomic signatures with normal inheritance patterns of epigenetic marks in animal models of in vitro culture will greatly impact our ability to identify embryos with high reproductive potential in the human clinic.
